Immunology researchers awarded Novartis Prizes; Rexahn Pharmaceuticals granted patent for new cancer-fighting compounds;

Immunology

Three scientists have been awarded Novartis Prizes for their groundbreaking research in the field of immunology. Release

Cancer

Rexahn Pharmaceuticals has been awarded a U.S. patent for new anti-tumor compounds that are inhibitors of an epidermal growth factor receptor (EGFR) often implicated in lung and colon cancer. Release

Rare Diseases

A rare disease called centronuclear myopathy--which weakens skeletal muscles so severely that children have trouble eating and breathing and often die before age 18--has been identified in dogs, a finding that could help scientists find new ways to diagnose and treat the disorder. Story

Stem Cells

Nail stem cells may be able to help regrow bones. News

IntelliCell Bioscienes has been granted a U.S. patent for its stem cell extraction technology to separate stromal vascular fraction cells from adipose (fat) tissue without using enzymes. Release